Abstract
IntroductionAtrial fibrillation is the most frequent sustained arrhythmia, with a prevalence of 3% in the general population, although with a higher prevalence in the elderly, hypertensive, obese and patients with structural heart disease. DiagnosisThe electrocardiographic diagnosis is based on the identification of the irregularly irregular pattern R-R characteristic. As part of the study, it is convenient to perform a transthoracic echocardiogram, which allows us to diagnose the presence of structural heart disease and to assess the atrial size, which is important for an ablation procedure, and a complete analysis with a thyroid profile, in order to rule out Other triggers, such as anemia, infection, or hyperthyroidism. ManagementThe management of this pathology is based on three pillars: antithrombotic therapy for the prevention of systemic embolism and cerebrovascular accidents, current in recent years thanks to the appearance of oral alternatives to classical anticoagulant therapy with vitamin antagonists K; Heart rate control with braking agents, especially beta-adrenergic blockers, but also calcium-antagonists and digoxin; And rhythm control strategies, both pharmacological and percutaneous, the latter increasingly widespread due to its greater effectiveness and low incidence of complications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Medicine - Programa de Formación Médica Continuada acreditado
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
